Law360, New York (November 1, 2007, 12:00 AM EDT) -- Despite ongoing debate over the rights of patent holders, World Trade Organization member nations are slowly moving forward with a key world trade protocol that will allow developing countries to arrange for compulsory export licenses from pharmaceutical companies for drugs to treat diseases that pose public health emergencies, such as HIV/AIDS and malaria.
Late last month, the European Union became the latest country to ratify the protocol after months of wrangling between Parliament members.
The EU Parliament also pledged to exclude protection of intellectual property rights...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.